4-aminopyridine has been researched along with bucladesine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Cox, RT; Walker, RJ | 1 |
| De Luis, DA; Gonzalez, C; López-López, JR | 1 |
| Hu, Q; Shi, YL | 1 |
| Fieber, LA | 1 |
| Bal, R; Oertel, D | 1 |
| Luykenaar, KD; Welsh, DG | 1 |
7 other study(ies) available for 4-aminopyridine and bucladesine
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
An analysis of the inhibitory responses of dopamine and octopamine on Helix central neurons.
Topics: 4-Aminopyridine; Adenylyl Cyclase Inhibitors; Aminopyridines; Animals; Bucladesine; Colforsin; Dopamine; Evoked Potentials; Helix, Snails; Imines; Membrane Potentials; Neuromuscular Depolarizing Agents; Neurons; Octopamine; Potassium Channels | 1988 |
Properties of a transient K+ current in chemoreceptor cells of rabbit carotid body.
Topics: 4-Aminopyridine; Action Potentials; Animals; Bucladesine; Carotid Body; Cells, Cultured; Chemoreceptor Cells; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Ions; Membrane Potentials; Rabbits; Sodium-Potassium-Exchanging ATPase | 1993 |
Characterization of an inward-rectifying potassium current in NG108-15 neuroblastoma x glioma cells.
Topics: 4-Aminopyridine; Barium; Bucladesine; Cadmium; Calcium; Cell Differentiation; Cesium; Cobalt; Cyclic AMP; Glioma; Neuroblastoma; Patch-Clamp Techniques; Potassium Channels; Quinidine; Tetraethylammonium; Tetraethylammonium Compounds; Tumor Cells, Cultured | 1997 |
Ionic currents in normal and neurofibromatosis type 1-affected human Schwann cells: induction of tumor cell K current in normal Schwann cells by cyclic AMP.
Topics: 4-Aminopyridine; Adolescent; Bucladesine; Cauda Equina; Cells, Cultured; Child; Colforsin; Cyclic AMP; Humans; Ion Channels; Membrane Potentials; Neurofibromatosis 1; Patch-Clamp Techniques; Potassium; Potassium Channels; Schwann Cells; Sodium; Tetraethylammonium; Tetrodotoxin; Thionucleotides; Tumor Cells, Cultured | 1998 |
Hyperpolarization-activated, mixed-cation current (I(h)) in octopus cells of the mammalian cochlear nucleus.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Barium; Bucladesine; Cadmium; Cardiotonic Agents; Cations; Cesium; Cochlear Nucleus; Guanosine Triphosphate; Kinetics; Membrane Potentials; Mice; Mice, Inbred ICR; Neurons; Patch-Clamp Techniques; Pyrimidines; Tetraethylammonium; Tetrodotoxin | 2000 |
Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in cerebral arteries.
Topics: 4-Aminopyridine; ADP Ribose Transferases; Animals; Botulinum Toxins; Bucladesine; Cerebral Arteries; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Delayed Rectifier Potassium Channels; Dibutyryl Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Female; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitroprusside; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Signal Transduction; Time Factors; Uridine Triphosphate; Vasoconstriction; Vasoconstrictor Agents | 2007 |